Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 5:46 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1201–1224 of 1,258 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Longitudinal Clear all

Conditions: Burns, Cytomegalovirus
Interventions: Not listed
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Fallopian Tube Adenocarcinoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma, Fallopian Tube Transitional Cell Carcinoma, Malignant Ovarian Brenner Tumor, Malignant Ovarian Clear Cell Tumor, Malignant Ovarian Endometrioid Tumor, Malignant Ovarian Mixed Epithelial Tumor, Malignant Ovarian Mucinous Tumor, Malignant Ovarian Neoplasm, Malignant Ovarian Serous Tumor, Malignant Ovarian Transitional Cell Tumor, Ovarian Adenocarcinoma, Primary Peritoneal Serous Adenocarcinoma, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Cancer, Stage IIIA Primary Peritoneal Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Cancer, Stage IIIB Primary Peritoneal Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Cancer, Stage IIIC Primary Peritoneal Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Cancer, Stage IV Primary Peritoneal Cancer, Undifferentiated Fallopian Tube Carcinoma, Undifferentiated Ovarian Carcinoma
Interventions: Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis; Other
Lead sponsor: Gynecologic Oncology Group; Network
Eligibility: 18 Years and older · Female only
Enrollment: 2,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2007
U.S. locations: 131
States / cities: Mobile, Alabama • Phoenix, Arizona • Fayetteville, Arkansas + 99 more

Conditions: Memory
Interventions: nap; Behavioral
Lead sponsor: University of Maryland, College Park; Other
Eligibility: 36 Months to 60 Months
Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 2
States / cities: College Park, Maryland • Amherst, Massachusetts

Conditions: Liver Diseases, Surgery
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2037
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Germline Mutation, Myelodysplastic Syndromes, Acute Myeloid Leukemia
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 1 Month to 120 Years
Enrollment: 510 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2035
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Solid Tumor, Hematologic Malignancy
Interventions: Multilevel Adherence Intervention; Behavioral
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 21 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Burnout
Interventions: mindfulness, standard medical education; Behavioral · Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: Not listed
Enrollment: 88 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Drinking Behavior
Interventions: Sequential Personalized Feedback Intervention Delivery, Simultaneous Personalized Feedback Intervention Delivery, Text Message Boosters; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 18 Years to 24 Years
Enrollment: 1,012 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Brain Concussion, Mild Traumatic Brain Injury, Headache, Post-Concussion Symptoms
Interventions: Repetitive Transcranial Magnetic Stimulation, Sham Repetitive Transcranial Magnetic Stimulation; Device
Lead sponsor: State University of New York - Upstate Medical University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Syracuse, New York

Conditions: Presumed Ocular Histoplasmosis
Interventions: Faricimab Injection [Vabysmo]; Drug
Lead sponsor: Cincinnati Eye Institute, Southwest Ohio; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: Cincinnati, Ohio • Dayton, Ohio

Conditions: Down Syndrome, Alzheimer's Dementia
Interventions: biospecimen collection, cognitive assessments, caregiver questionnaire, Florbetapir F18 imaging, MRI, Fludeoxyglucose F18 (FDG), Tau Pet, Actigraphy; Procedure · Other
Lead sponsor: St. Joseph's Hospital and Medical Center, Phoenix; Other
Eligibility: 21 Years and older
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Cancer Colon, Gastrointestinal Disease
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Fall
Interventions: Balance Exercises - Smartphone Delivery, Balance Exercises - Traditional Paper Delivery; Device · Other
Lead sponsor: Binghamton University; Other
Eligibility: 65 Years to 90 Years
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Binghamton, New York

Conditions: Dental Caries
Interventions: Oral Samples; Other
Lead sponsor: University of Florida; Other
Eligibility: 2 Years to 7 Years
Enrollment: 232 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Asthma, Severe Persistent Asthma
Interventions: Triamcinolone Acetonide; Drug
Lead sponsor: Sally E. Wenzel MD; Other
Eligibility: 6 Years and older
Enrollment: 715 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2022
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Effects of Chemotherapy
Interventions: Not listed
Lead sponsor: University of Pennsylvania; Other
Eligibility: 15 Years to 45 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2013
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania • Radnor, Pennsylvania

Conditions: Spinal Cord Injuries
Interventions: Tests of sympathetic inhibition, Tests of above level sympathetic activation, Testing of below level sympathetic activation; Diagnostic Test
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 75 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Premature Infant
Interventions: Not listed
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: Up to 3 Years
Enrollment: 393 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2027
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Prostate Carcinoma
Interventions: Non-Interventional Study; Other
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older · Male only
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: Los Angeles, California

Conditions: Failure to Thrive
Interventions: Training; Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 194 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Head and Neck Squamous Cell Carcinoma
Interventions: Not listed
Lead sponsor: Tempus AI; Industry
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 31
States / cities: Duarte, California • Los Angeles, California • Palo Alto, California + 25 more

Conditions: Friedreich Ataxia
Interventions: Not listed
Lead sponsor: University of Minnesota; Other
Eligibility: 10 Years and older
Enrollment: 85 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2022
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Erection; Incomplete
Interventions: Pornography Abstinence; Behavioral
Lead sponsor: Efforia, Inc; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Diabetes Mellitus, Osteoporosis
Interventions: Not listed
Lead sponsor: Creighton University; Other
Eligibility: 19 Years to 50 Years
Enrollment: 123 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Omaha, Nebraska

Search by objective public record fields.

Effect of Burn Size on Cytomegalovirus Reactivation and Correlates of T Cell Immune Function in Burned Patients

YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving Chemotherapy

Longitudinal Investigation of Sleep, Memory, and Brain Development Across the Nap Transition

Longitudinal Outcomes in Hepatic Resection

Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants

Implementation of an Oral Chemotherapy Adherence Intervention

Longitudinal Mindfulness Intervention to Decrease Burnout in Medical Residents

Motivating Campus Change Study

Repetitive Transcranial Magnetic Stimulation for Post-concussion Headaches

A Prospective Longitudinal Analysis of Faricimab (Vabysmo 6mg) For Choroidal Neovascularization in Presumed Ocular Histoplasmosis Syndrome

Relationship Between Down Syndrome (DS) and Alzheimer's Disease (AD)

Time Longitudinal Study of the Microbiome in Colorectal Cancer Subjects

Use of a Smartphone to Assess Balance and Provide Intervention to Older Adults at Home

Oral Alkali Production and Caries Prevention in Children (Longitudinal)

Implications and Stability of Clinical and Molecular Phenotypes of Severe Asthma

The Longitudinal Ovarian Reserve Study

Longitudinal Autonomic Characterization as a Predictor for Secondary Medical Complications Post-SCI

Cincinnati Infant Neurodevelopment Early Prediction Study (CINEPS)

Longitudinal Advanced Prostate Cancer Cohort (LAPCC)

Palliative Care Population Management Project for Integrated Care Management Program for High-Risk Patients

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

Early and Longitudinal Assessment of Neurodegeneration in the Brain and Spinal Cord in Friedreich's Ataxia

Pornography Abstinence and Nocturnal Erections in Adult Men

Type 1 Diabetes Mellitus Effect on Bone Mineral Density